GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Millennium Pharmacon International Tbk (ISX:SDPC) » Definitions » Beneish M-Score

PT Millennium Pharmacon International Tbk (ISX:SDPC) Beneish M-Score : -1.90 (As of Apr. 07, 2025)


View and export this data going back to 1990. Start your Free Trial

What is PT Millennium Pharmacon International Tbk Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.9 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for PT Millennium Pharmacon International Tbk's Beneish M-Score or its related term are showing as below:

ISX:SDPC' s Beneish M-Score Range Over the Past 10 Years
Min: -3.09   Med: -1.9   Max: 10.44
Current: -1.9

During the past 13 years, the highest Beneish M-Score of PT Millennium Pharmacon International Tbk was 10.44. The lowest was -3.09. And the median was -1.90.


PT Millennium Pharmacon International Tbk Beneish M-Score Historical Data

The historical data trend for PT Millennium Pharmacon International Tbk's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Millennium Pharmacon International Tbk Beneish M-Score Chart

PT Millennium Pharmacon International Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.24 -2.80 -2.39 -1.90 -1.90

PT Millennium Pharmacon International Tbk Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.82 -1.90 -1.83 -1.66 -1.90

Competitive Comparison of PT Millennium Pharmacon International Tbk's Beneish M-Score

For the Medical Distribution subindustry, PT Millennium Pharmacon International Tbk's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Millennium Pharmacon International Tbk's Beneish M-Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Millennium Pharmacon International Tbk's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where PT Millennium Pharmacon International Tbk's Beneish M-Score falls into.


;
;

PT Millennium Pharmacon International Tbk Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of PT Millennium Pharmacon International Tbk for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9641+0.528 * 1.0211+0.404 * 1.1922+0.892 * 1.185+0.115 * 0.9997
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9318+4.679 * 0.075522-0.327 * 1.0259
=-1.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was Rp850,042 Mil.
Revenue was 983825.881 + 966552.749 + 973732.361 + 923726.116 = Rp3,847,837 Mil.
Gross Profit was 85226.951 + 84739.709 + 82226.487 + 76470.737 = Rp328,664 Mil.
Total Current Assets was Rp1,594,401 Mil.
Total Assets was Rp1,783,742 Mil.
Property, Plant and Equipment(Net PPE) was Rp57,954 Mil.
Depreciation, Depletion and Amortization(DDA) was Rp22,277 Mil.
Selling, General, & Admin. Expense(SGA) was Rp65,275 Mil.
Total Current Liabilities was Rp1,411,472 Mil.
Long-Term Debt & Capital Lease Obligation was Rp43,113 Mil.
Net Income was 5157.096 + 8238.295 + 7090.826 + 6356.979 = Rp26,843 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = Rp0 Mil.
Cash Flow from Operations was -1414.101 + -46141.299 + -101105.443 + 40792.646 = Rp-107,868 Mil.
Total Receivables was Rp744,074 Mil.
Revenue was 873526.097 + 812678.557 + 753587.038 + 807446.318 = Rp3,247,238 Mil.
Gross Profit was 74205.588 + 72206.84 + 69462.783 + 67352.898 = Rp283,228 Mil.
Total Current Assets was Rp1,407,479 Mil.
Total Assets was Rp1,551,780 Mil.
Property, Plant and Equipment(Net PPE) was Rp48,426 Mil.
Depreciation, Depletion and Amortization(DDA) was Rp18,607 Mil.
Selling, General, & Admin. Expense(SGA) was Rp59,118 Mil.
Total Current Liabilities was Rp1,232,638 Mil.
Long-Term Debt & Capital Lease Obligation was Rp886 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(850042.464 / 3847837.107) / (744073.513 / 3247238.01)
=0.220914 / 0.22914
=0.9641

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(283228.109 / 3247238.01) / (328663.884 / 3847837.107)
=0.087221 / 0.085415
=1.0211

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1594400.966 + 57953.939) / 1783742.47) / (1 - (1407478.926 + 48425.711) / 1551779.568)
=0.073658 / 0.061784
=1.1922

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3847837.107 / 3247238.01
=1.185

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(18607.006 / (18607.006 + 48425.711)) / (22277.476 / (22277.476 + 57953.939))
=0.277581 / 0.277665
=0.9997

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(65274.723 / 3847837.107) / (59117.987 / 3247238.01)
=0.016964 / 0.018206
=0.9318

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((43112.528 + 1411471.846) / 1783742.47) / ((885.745 + 1232637.9) / 1551779.568)
=0.815468 / 0.794909
=1.0259

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(26843.196 - 0 - -107868.197) / 1783742.47
=0.075522

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

PT Millennium Pharmacon International Tbk has a M-score of -1.90 suggests that the company is unlikely to be a manipulator.


PT Millennium Pharmacon International Tbk Beneish M-Score Related Terms

Thank you for viewing the detailed overview of PT Millennium Pharmacon International Tbk's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Millennium Pharmacon International Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan.Sultan Iskandar Muda No 18, Crown Bungur Arteri Lantai 2-4th Floors, Jakarta, IDN, 12240
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The operating segments of the group are Prescription medicine, Non-prescription medicine, and Medical devices, of which the majority of the revenue is derived from the Prescription Medicine segment.. The company's geographical segments are Java, Sumatera, Kalimantan, Sulawesi, and Bali.

PT Millennium Pharmacon International Tbk Headlines

No Headlines